FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3122472272> ?p ?o ?g. }

• W3122472272 endingPage "592" @default.
• W3122472272 startingPage "584" @default.
• W3122472272 abstract "Abstract Although measurable residual disease (MRD) at the time of allogeneic hematopoietic cell transplantation (allo-HCT) has been reported to be an important prognostic factor for Philadelphia chromosome (Ph)–positive acute lymphoblastic leukemia (ALL) during first complete remission (CR1), the prognostic impact of MRD is unclear during second CR (CR2). To clarify the impact of MRD for both CR1 and CR2, we analyzed data from a registry database including 1625 adult patients with Ph+ ALL who underwent first allo-HCT during either CR1 or CR2 between 2002 and 2017. Adjusted overall and leukemia-free survival rates at 4 years were 71% and 64%, respectively, for patients undergoing allo-HCT during CR1 with MRD−, 55% and 43% during CR1 with MRD+, 51% and 49% during CR2 with MRD−, and 38% and 29% during CR2 with MRD+. Although survival rates were significantly better among patients with CR1 MRD− than among patients with CR2 MRD−, no significant difference was observed in survival rate between patients with CR1 MRD+ and CR2 MRD−. Relapse rates after 4 years were 16% in patients with CR1 MRD−, 29% in CR1 MRD+, 21% in patients with CR2 MRD−, and 46% in patients with CR2 MRD+. No significant difference was identified in relapse rate between patients with CR1 MRD− and CR2 MRD−. CR2 MRD− was not a significant risk factor for relapse in multivariate analysis (hazard ratio, 1.26; 95% confidence interval, 0.69-2.29; P = .45 vs CR1 MRD−). MRD at time of allo-HCT was an important risk factor in patients with Ph+ ALL during both CR1 and CR2." @default.
• W3122472272 created "2021-02-01" @default.
• W3122472272 creator A5001196940 @default.
• W3122472272 creator A5003175331 @default.
• W3122472272 creator A5004509292 @default.
• W3122472272 creator A5008627739 @default.
• W3122472272 creator A5009975594 @default.
• W3122472272 creator A5010422580 @default.
• W3122472272 creator A5020985742 @default.
• W3122472272 creator A5021082730 @default.
• W3122472272 creator A5032219696 @default.
• W3122472272 creator A5036559617 @default.
• W3122472272 creator A5045110650 @default.
• W3122472272 creator A5046989635 @default.
• W3122472272 creator A5049803192 @default.
• W3122472272 creator A5065656835 @default.
• W3122472272 creator A5067604014 @default.
• W3122472272 creator A5074346318 @default.
• W3122472272 creator A5075743968 @default.
• W3122472272 creator A5077166961 @default.
• W3122472272 creator A5028744470 @default.
• W3122472272 date "2021-01-25" @default.
• W3122472272 modified "2023-10-15" @default.
• W3122472272 title "Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2" @default.
• W3122472272 cites W1562876511 @default.
• W3122472272 cites W1838408716 @default.
• W3122472272 cites W1973617793 @default.
• W3122472272 cites W1989658067 @default.
• W3122472272 cites W2013779251 @default.
• W3122472272 cites W2022129113 @default.
• W3122472272 cites W2030621192 @default.
• W3122472272 cites W2038403820 @default.
• W3122472272 cites W2052690356 @default.
• W3122472272 cites W2073282372 @default.
• W3122472272 cites W2077084194 @default.
• W3122472272 cites W2085656861 @default.
• W3122472272 cites W2101635775 @default.
• W3122472272 cites W2107925822 @default.
• W3122472272 cites W2121574619 @default.
• W3122472272 cites W2121990442 @default.
• W3122472272 cites W2127742735 @default.
• W3122472272 cites W2134638406 @default.
• W3122472272 cites W2135492799 @default.
• W3122472272 cites W2147109509 @default.
• W3122472272 cites W2156617860 @default.
• W3122472272 cites W2167765664 @default.
• W3122472272 cites W2169978372 @default.
• W3122472272 cites W2187668060 @default.
• W3122472272 cites W2269223862 @default.
• W3122472272 cites W2296061031 @default.
• W3122472272 cites W2341215846 @default.
• W3122472272 cites W2406225326 @default.
• W3122472272 cites W2419639370 @default.
• W3122472272 cites W2533254789 @default.
• W3122472272 cites W2566332174 @default.
• W3122472272 cites W2577600752 @default.
• W3122472272 cites W2591709377 @default.
• W3122472272 cites W2599899418 @default.
• W3122472272 cites W2613210669 @default.
• W3122472272 cites W2618073389 @default.
• W3122472272 cites W2725721905 @default.
• W3122472272 cites W2726522927 @default.
• W3122472272 cites W2773044425 @default.
• W3122472272 cites W2774624088 @default.
• W3122472272 cites W2787301955 @default.
• W3122472272 cites W2804546534 @default.
• W3122472272 cites W2896845000 @default.
• W3122472272 cites W2904879715 @default.
• W3122472272 cites W2955874201 @default.
• W3122472272 cites W2975851402 @default.
• W3122472272 cites W2981412985 @default.
• W3122472272 cites W2981828827 @default.
• W3122472272 cites W3025423143 @default.
• W3122472272 cites W4237287329 @default.
• W3122472272 doi "https://doi.org/10.1182/bloodadvances.2020003536" @default.
• W3122472272 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7839376" @default.
• W3122472272 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33496752" @default.
• W3122472272 hasPublicationYear "2021" @default.
• W3122472272 type Work @default.
• W3122472272 sameAs 3122472272 @default.
• W3122472272 citedByCount "4" @default.
• W3122472272 countsByYear W31224722722022 @default.
• W3122472272 countsByYear W31224722722023 @default.
• W3122472272 crossrefType "journal-article" @default.
• W3122472272 hasAuthorship W3122472272A5001196940 @default.
• W3122472272 hasAuthorship W3122472272A5003175331 @default.
• W3122472272 hasAuthorship W3122472272A5004509292 @default.
• W3122472272 hasAuthorship W3122472272A5008627739 @default.
• W3122472272 hasAuthorship W3122472272A5009975594 @default.
• W3122472272 hasAuthorship W3122472272A5010422580 @default.
• W3122472272 hasAuthorship W3122472272A5020985742 @default.
• W3122472272 hasAuthorship W3122472272A5021082730 @default.
• W3122472272 hasAuthorship W3122472272A5028744470 @default.
• W3122472272 hasAuthorship W3122472272A5032219696 @default.
• W3122472272 hasAuthorship W3122472272A5036559617 @default.
• W3122472272 hasAuthorship W3122472272A5045110650 @default.
• W3122472272 hasAuthorship W3122472272A5046989635 @default.
• W3122472272 hasAuthorship W3122472272A5049803192 @default.

• next